As concerns about AstraZeneca’s coronavirus vaccines grew, Britain began rolling out its third coronavirus vaccine, manufactured by American company Moderna.
The vaccine from AstraZeneca-Oxford University and Pfizer-BioNTech joined those from AstraZeneca-Oxford University and Pfizer-BioNTech in Britain’s arsenal against Covid-19. In a timely diversification of Britain’s rollout, the first jabs of the two-stage Moderna inoculation were injected at a hospital in Wales, hailed by Prime Minister Boris Johnson.
“We’ve put an order for 17 million doses, which will be shipped to weapons throughout the United Kingdom in the coming weeks. Please get your vaccine as soon as possible after being contacted “He sent out a tweet.
AstraZeneca’s supply issues threatened to disrupt the UK’s immunization campaign this month, and worries are growing about a possible connection between the vaccine and unusual blood clots in a small number of recipients.
Late Tuesday, Oxford University announced that a British trial of the AstraZeneca vaccine on children had been halted. The university said the trial had raised “no safety issues,” but it was waiting for more data from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom before restarting it.
The MHRA says it is looking into clotting cases, amid rumors that the regulator may join some European Union countries in restricting access to children under the age of 18. Out of 18 million doses administered in the UK, the MHRA recorded 30 cases of blood clotting, seven of which were fatal.
The European Medicines Agency (EMA) is also reexamining the situation, but the World Health Organization maintains that the vaccine is safe. Kent Woods, a former director of the MHRA and the EMA in the United Kingdom, told LBC radio that the risks of Covid were much higher and that he had “no doubts” about the AstraZeneca vaccine.
However, Maggie Wearmouth, a member of the government’s Joint Committee on Vaccination and Immunisation, told the Daily Telegraph that “slowing things down” with the launch “until we’re completely sure” may be prudent. Any delays could jeopardize the British government’s plan to gradually ease its current coronavirus quarantine, with all adults receiving their first dose by the end of July.